首页> 外文期刊>Chemical science >Proline bulky substituents consecutively act as steric hindrances and directing groups in a Michael/Conia-ene cascade reaction under synergistic catalysis
【24h】

Proline bulky substituents consecutively act as steric hindrances and directing groups in a Michael/Conia-ene cascade reaction under synergistic catalysis

机译:在协同催化下,脯氨酸庞大的取代基在迈克尔/科尼亚-烯级联反应中连续充当空间位阻和导向基团

获取原文
           

摘要

In this study, we report a highly stereoselective and versatile synthesis of spiro pyrazolones, promising motifs that are being employed as pharmacophores. The new synthetic strategy merges organocatalysis and metal catalysis to create a synergistic catalysis using proline derivatives and Pd catalysts. This protocol is suitable for late-stage functionalization, which is very important in drug discovery. Additionally, a thorough computational study proved to be very useful to elucidate the function of the different catalysts along the reaction, showing a peculiar feature: the –CPh _(2) OSiMe _(3) group of the proline catalyst switches its role during the reaction. In the initial Michael reaction, this group plays its commonly-assumed role of bulky blocking group, but the same group generates π–Pd interactions and acts as a directing group in the subsequent Pd-catalyzed Conia-ene reaction. This finding might be very relevant especially for processes with many steps, such as cascade reactions, in which functional groups are assumed to play the same role during all reaction steps.
机译:在这项研究中,我们报告了螺吡唑啉酮的高度立体选择性和通用性合成,有希望的基序被用作药效基团。新的合成策略将有机催化和金属催化相结合,从而使用脯氨酸衍生物和Pd催化剂产生协同催化作用。该协议适用于后期功能化,这在药物发现中非常重要。此外,事实证明,透彻的计算研究对于阐明不同催化剂在反应中的功能非常有用,它显示出一个独特的特征:脯氨酸催化剂的-CPh _(2)OSiMe _(3)基团在催化过程中转换其作用。反应。在最初的迈克尔反应中,该基团发挥其通常假定的庞大阻滞基团的作用,但同一基团产生π–Pd相互作用,并在随后的Pd催化的Conia-ene反应中充当导向基团。特别是对于具有许多步骤的过程(例如级联反应)而言,这一发现可能非常相关,在该过程中,假定官能团在所有反应步骤中都起着相同的作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号